Severe Euglycemic Diabetic Ketoacidosis After Semaglutide-Associated Poor Intake Despite Empagliflozin Discontinuation: A Case Report
International Medical Case Reports Journal · 2026-10 · Volume 19 · 1-6
DOI: 10.2147/imcrj.s650090 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Medical Case Reports Journal, 2026-10. Verfasst von Kianoush Niknam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Legacy Salmon Creek Medical Center, Vancouver, WA, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Benzhydryl Compounds, Glucagon-Like Peptides, Diabetic Ketoacidosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Legacy Salmon Creek Medical Center, Vancouver, WA, USA.
- Department of Pulmonary and Critical Care, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Kianoush Niknam, Tahmoores Niknam
Zitieren
APA
Niknam, K., & Niknam, T. (2026). Severe Euglycemic Diabetic Ketoacidosis After Semaglutide-Associated Poor Intake Despite Empagliflozin Discontinuation: A Case Report. International Medical Case Reports Journal, Volume 19, 1-6. https://doi.org/10.2147/imcrj.s650090
Vancouver
Niknam K, Niknam T. Severe Euglycemic Diabetic Ketoacidosis After Semaglutide-Associated Poor Intake Despite Empagliflozin Discontinuation: A Case Report. International Medical Case Reports Journal. 2026;Volume 19:1-6. doi:10.2147/imcrj.s650090
BibTeX
@article{Niknam2026,
author = {Niknam, Kianoush and Niknam, Tahmoores},
title = {Severe Euglycemic Diabetic Ketoacidosis After Semaglutide-Associated Poor Intake Despite Empagliflozin Discontinuation: A Case Report},
journal = {International Medical Case Reports Journal},
year = {2026},
volume = {Volume 19},
pages = {1--6},
doi = {10.2147/imcrj.s650090}
}
EUVIMED